bye bye biotech capitol, page-3

yes, the original problem has finally dawned on this bunch of indifferent fools, posing as competant managers , ie., a reputation does not a clinical trial make, this has been obvious for years, but the reality has been ignored by the Dandy Deltra's of the corporate world, until now that is, they are on their own now, what chance another cap raising?--not a chance, this m/ment should be charged for professional misconduct, nevermind a class action, but like their ilk, they will run away as fast as their fancy pants let them